Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 99011-02-6
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of imiquimod during breastfeeding. However, because the drug is used on a limited surface area and poorly absorbed into the maternal circulation, effects on the infant are unlikely. If imiquimod is required by the mother, it is not a reason to discontinue breastfeeding. Do not apply imiquimod to the breast or nipple and ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Imiquimod
CAS Registry Number
99011-02-6
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Ingenol Mebutate.[Drugs and Lactation Database (...]Review Ingenol Mebutate.. Drugs and Lactation Database (LactMed®). 2006
- Review Fluorouracil.[Drugs and Lactation Database (...]Review Fluorouracil.. Drugs and Lactation Database (LactMed®). 2006
- Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.[J Invest Dermatol. 2006]Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.Thatcher TH, Luzina I, Fishelevich R, Tomai MA, Miller RL, Gaspari AA. J Invest Dermatol. 2006 Apr; 126(4):821-31.
- Review Luliconazole.[Drugs and Lactation Database (...]Review Luliconazole.. Drugs and Lactation Database (LactMed®). 2006
- Review Trifarotene.[Drugs and Lactation Database (...]Review Trifarotene.. Drugs and Lactation Database (LactMed®). 2006
- Imiquimod - Drugs and Lactation Database (LactMed®)Imiquimod - Drugs and Lactation Database (LactMed®)
- Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elev...Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation - GeneReviews®
- Clotiazepam - Drugs and Lactation Database (LactMed®)Clotiazepam - Drugs and Lactation Database (LactMed®)
- cell division control protein 42 homolog isoform 1 precursor [Homo sapiens]cell division control protein 42 homolog isoform 1 precursor [Homo sapiens]gi|89903012|ref|NP_001034891.1|Protein
- Homo sapiensHomo sapiensRefSeq annotation of the human reference genome assemblyBioProject
Your browsing activity is empty.
Activity recording is turned off.
See more...